Stock Scorecard
Stock Summary for Accuray Inc (ARAY) - $0.83 as of 12/26/2025 7:36:14 PM EST
Total Score
8 out of 30
Safety Score
16 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ARAY
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ARAY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ARAY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ARAY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ARAY (16 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ARAY
Financial Details for ARAY
Company Overview |
|
|---|---|
| Ticker | ARAY |
| Company Name | Accuray Inc |
| Country | USA |
| Description | Accuray Incorporated is a pioneering force in precision oncology, focusing on advanced radiosurgery and radiation therapy systems that deliver exceptional targeting precision for tumor treatment. Based in Sunnyvale, California, the company serves a global clientele, offering innovative healthcare solutions across the Americas, Europe, the Middle East, and Asia-Pacific. Accuray is dedicated to enhancing clinical outcomes and transforming patient care, making its state-of-the-art technologies vital in the ongoing battle against cancer. With a robust product portfolio and a strategic vision, Accuray is well-positioned to seize growth opportunities in the expanding oncology market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/4/2026 |
Stock Price History |
|
| Last Day Price | 0.83 |
| Price 4 Years Ago | 4.77 |
| Last Day Price Updated | 12/26/2025 7:36:14 PM EST |
| Last Day Volume | 619,375 |
| Average Daily Volume | 1,247,503 |
| 52-Week High | 2.95 |
| 52-Week Low | 0.81 |
| Last Price to 52 Week Low | 2.47% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 33.49 |
| Sector PE | 128.95 |
| 5-Year Average PE | -32.86 |
| Free Cash Flow Ratio | 1.48 |
| Industry Free Cash Flow Ratio | 23.35 |
| Sector Free Cash Flow Ratio | 31.21 |
| Current Ratio Most Recent Quarter | 1.55 |
| Total Cash Per Share | 0.56 |
| Book Value Per Share Most Recent Quarter | 0.55 |
| Price to Book Ratio | 1.58 |
| Industry Price to Book Ratio | 4.25 |
| Sector Price to Book Ratio | 43.34 |
| Price to Sales Ratio Twelve Trailing Months | 0.22 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.44 |
| Sector Price to Sales Ratio Twelve Trailing Months | 21.21 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 113,341,000 |
| Market Capitalization | 94,073,030 |
| Institutional Ownership | 69.81% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 10.10% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -96.20% |
| Annual Earnings Growth | 89.77% |
| Reported EPS 12 Trailing Months | -0.16 |
| Reported EPS Past Year | -0.14 |
| Reported EPS Prior Year | -0.02 |
| Net Income Twelve Trailing Months | -19,315,000 |
| Net Income Past Year | -1,591,000 |
| Net Income Prior Year | -15,545,000 |
| Quarterly Revenue Growth YOY | 16.80% |
| 5-Year Revenue Growth | 3.67% |
| Operating Margin Twelve Trailing Months | 3.73% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 63,916,000 |
| Total Cash Past Year | 57,416,000 |
| Total Cash Prior Year | 68,570,000 |
| Net Cash Position Most Recent Quarter | -63,400,000 |
| Net Cash Position Past Year | -66,370,000 |
| Long Term Debt Past Year | 123,786,000 |
| Long Term Debt Prior Year | 164,400,000 |
| Total Debt Most Recent Quarter | 127,316,000 |
| Equity to Debt Ratio Past Year | 0.40 |
| Equity to Debt Ratio Most Recent Quarter | 0.33 |
| Total Stockholder Equity Past Year | 81,169,000 |
| Total Stockholder Equity Prior Year | 45,084,000 |
| Total Stockholder Equity Most Recent Quarter | 61,867,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 11,803,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.10 |
| Free Cash Flow Past Year | -5,663,000 |
| Free Cash Flow Prior Year | -15,505,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.08 |
| MACD Signal | -0.07 |
| 20-Day Bollinger Lower Band | 0.77 |
| 20-Day Bollinger Middle Band | 1.36 |
| 20-Day Bollinger Upper Band | 1.96 |
| Beta | 1.07 |
| RSI | 30.71 |
| 50-Day SMA | 1.57 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 12/26/2025 5:28:18 PM EST |